Glaukos Corporation (GKOS)
USD 92.91
(3.15%)
USD 92.91
(3.15%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 41.98 Million USD | 10.95% |
| 2022 | 37.84 Million USD | 64.45% |
| 2021 | 23.01 Million USD | 45.56% |
| 2020 | 15.8 Million USD | -62.87% |
| 2019 | 42.57 Million USD | 220.57% |
| 2018 | 13.28 Million USD | 18.36% |
| 2017 | 11.22 Million USD | 63.97% |
| 2016 | 6.84 Million USD | 67.05% |
| 2015 | 4.09 Million USD | 81.44% |
| 2014 | 2.25 Million USD | 21.86% |
| 2013 | 1.85 Million USD | 102.51% |
| 2012 | 915 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 56.48 Million USD | 12.54% |
| 2024 Q1 | 50.18 Million USD | 19.53% |
| 2024 Q3 | 59.89 Million USD | 6.05% |
| 2023 Q3 | 39.78 Million USD | 0.85% |
| 2023 Q1 | 40.45 Million USD | 6.91% |
| 2023 Q2 | 39.44 Million USD | -2.49% |
| 2023 Q4 | 41.98 Million USD | 5.54% |
| 2023 FY | 41.98 Million USD | 10.95% |
| 2022 Q4 | 37.84 Million USD | 10.7% |
| 2022 Q2 | 27.84 Million USD | 12.68% |
| 2022 Q3 | 34.18 Million USD | 22.77% |
| 2022 Q1 | 24.7 Million USD | 7.37% |
| 2022 FY | 37.84 Million USD | 64.45% |
| 2021 Q1 | 15.27 Million USD | -3.4% |
| 2021 FY | 23.01 Million USD | 45.56% |
| 2021 Q4 | 23.01 Million USD | 16.69% |
| 2021 Q3 | 19.72 Million USD | 12.69% |
| 2021 Q2 | 17.5 Million USD | 14.6% |
| 2020 Q3 | 19.89 Million USD | -5.68% |
| 2020 Q4 | 15.8 Million USD | -20.52% |
| 2020 FY | 15.8 Million USD | -62.87% |
| 2020 Q1 | 27.69 Million USD | -34.95% |
| 2020 Q2 | 21.08 Million USD | -23.87% |
| 2019 Q4 | 42.57 Million USD | 232.61% |
| 2019 Q1 | 13.43 Million USD | 1.13% |
| 2019 Q3 | 12.8 Million USD | -8.81% |
| 2019 Q2 | 14.03 Million USD | 4.51% |
| 2019 FY | 42.57 Million USD | 220.57% |
| 2018 Q1 | 12.78 Million USD | 13.9% |
| 2018 Q4 | 13.28 Million USD | -1.88% |
| 2018 Q3 | 13.53 Million USD | -1.99% |
| 2018 Q2 | 13.81 Million USD | 8.06% |
| 2018 FY | 13.28 Million USD | 18.36% |
| 2017 Q1 | 7.48 Million USD | 9.37% |
| 2017 FY | 11.22 Million USD | 63.97% |
| 2017 Q4 | 11.22 Million USD | 25.16% |
| 2017 Q3 | 8.96 Million USD | 6.97% |
| 2017 Q2 | 8.38 Million USD | 11.98% |
| 2016 Q4 | 6.84 Million USD | 6.06% |
| 2016 Q2 | 5.51 Million USD | 8.89% |
| 2016 Q1 | 5.06 Million USD | 23.53% |
| 2016 FY | 6.84 Million USD | 67.05% |
| 2016 Q3 | 6.45 Million USD | 17.09% |
| 2015 Q1 | 2.53 Million USD | 12.4% |
| 2015 Q2 | 2.9 Million USD | 14.58% |
| 2015 FY | 4.09 Million USD | 81.44% |
| 2015 Q4 | 4.09 Million USD | 29.94% |
| 2015 Q3 | 3.15 Million USD | 8.43% |
| 2014 Q1 | 2.27 Million USD | 22.67% |
| 2014 FY | 2.25 Million USD | 21.86% |
| 2014 Q4 | 2.25 Million USD | 0.0% |
| 2014 Q2 | 2.33 Million USD | 2.51% |
| 2013 FY | 1.85 Million USD | 102.51% |
| 2013 Q4 | 1.85 Million USD | 0.0% |
| 2013 Q3 | 1.85 Million USD | 0.0% |
| 2012 FY | 915 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Abbott Laboratories | 6.57 Billion USD | 99.361% |
| Allurion Technologies Inc. | 6.17 Million USD | -580.376% |
| Artivion, Inc. | 81.97 Million USD | 48.783% |
| Avanos Medical, Inc. | 163.2 Million USD | 74.273% |
| Butterfly Network, Inc. | 75.83 Million USD | 44.637% |
| Butterfly Network, Inc. | 75.83 Million USD | 44.637% |
| Bio-Rad Laboratories, Inc. | 780.51 Million USD | 94.621% |
| Boston Scientific Corporation | 2.48 Billion USD | 98.31% |
| CONMED Corporation | 318.32 Million USD | 86.81% |
| Edwards Lifesciences Corporation | 1.16 Billion USD | 96.406% |
| Paragon 28, Inc. | 98.06 Million USD | 57.184% |
| Globus Medical, Inc. | 848.13 Million USD | 95.05% |
| Inspire Medical Systems, Inc. | 33.88 Million USD | -23.907% |
| Integer Holdings Corporation | 239.71 Million USD | 82.485% |
| Medtronic plc | 5.21 Billion USD | 99.195% |
| Myomo, Inc. | 1.8 Million USD | -2228.02% |
| Nevro Corp. | 118.67 Million USD | 64.621% |
| Owlet, Inc. | 6.49 Million USD | -546.635% |
| Penumbra, Inc. | 388.02 Million USD | 89.18% |
| Vicarious Surgical Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 2.39 Billion USD | 98.247% |
| Sonendo, Inc. | 11.07 Million USD | -279.14% |
| STERIS plc | 674.53 Million USD | 93.776% |
| Stryker Corporation | 4.84 Billion USD | 99.133% |
| Vapotherm, Inc. | 22.96 Million USD | -82.802% |
| Zimmer Biomet Holdings, Inc. | 2.38 Billion USD | 98.24% |